Control Bionics (Australia) Market Value
| CBL Stock | 0.07 0 1.47% |
| Symbol | Control |
Control Bionics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Control Bionics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Control Bionics.
| 10/26/2025 |
| 01/24/2026 |
If you would invest 0.00 in Control Bionics on October 26, 2025 and sell it all today you would earn a total of 0.00 from holding Control Bionics or generate 0.0% return on investment in Control Bionics over 90 days. Control Bionics is related to or competes with QBE Insurance, Insurance Australia, Macquarie Technology, Air New, Retail Food, Charter Hall, and Janison Education. Control Bionics is entity of Australia. It is traded as Stock on AU exchange. More
Control Bionics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Control Bionics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Control Bionics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.16 | |||
| Information Ratio | 0.1249 | |||
| Maximum Drawdown | 75.73 | |||
| Value At Risk | (7.14) | |||
| Potential Upside | 14.49 |
Control Bionics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Control Bionics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Control Bionics' standard deviation. In reality, there are many statistical measures that can use Control Bionics historical prices to predict the future Control Bionics' volatility.| Risk Adjusted Performance | 0.1066 | |||
| Jensen Alpha | 1.19 | |||
| Total Risk Alpha | 0.3722 | |||
| Sortino Ratio | 0.2333 | |||
| Treynor Ratio | 1.03 |
Control Bionics January 24, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1066 | |||
| Market Risk Adjusted Performance | 1.04 | |||
| Mean Deviation | 5.39 | |||
| Semi Deviation | 4.0 | |||
| Downside Deviation | 5.16 | |||
| Coefficient Of Variation | 752.01 | |||
| Standard Deviation | 9.65 | |||
| Variance | 93.04 | |||
| Information Ratio | 0.1249 | |||
| Jensen Alpha | 1.19 | |||
| Total Risk Alpha | 0.3722 | |||
| Sortino Ratio | 0.2333 | |||
| Treynor Ratio | 1.03 | |||
| Maximum Drawdown | 75.73 | |||
| Value At Risk | (7.14) | |||
| Potential Upside | 14.49 | |||
| Downside Variance | 26.65 | |||
| Semi Variance | 16.04 | |||
| Expected Short fall | (9.37) | |||
| Skewness | 3.95 | |||
| Kurtosis | 22.45 |
Control Bionics Backtested Returns
Control Bionics is out of control given 3 months investment horizon. Control Bionics secures Sharpe Ratio (or Efficiency) of 0.17, which signifies that the company had a 0.17 % return per unit of risk over the last 3 months. We were able to break down and interpolate twenty-seven different technical indicators, which can help you to evaluate if expected returns of 1.63% are justified by taking the suggested risk. Use Control Bionics Downside Deviation of 5.16, mean deviation of 5.39, and Risk Adjusted Performance of 0.1066 to evaluate company specific risk that cannot be diversified away. Control Bionics holds a performance score of 13 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 1.24, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Control Bionics will likely underperform. Use Control Bionics information ratio, total risk alpha, treynor ratio, as well as the relationship between the jensen alpha and sortino ratio , to analyze future returns on Control Bionics.
Auto-correlation | -0.34 |
Poor reverse predictability
Control Bionics has poor reverse predictability. Overlapping area represents the amount of predictability between Control Bionics time series from 26th of October 2025 to 10th of December 2025 and 10th of December 2025 to 24th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Control Bionics price movement. The serial correlation of -0.34 indicates that nearly 34.0% of current Control Bionics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.34 | |
| Spearman Rank Test | 0.09 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Control Stock Analysis
When running Control Bionics' price analysis, check to measure Control Bionics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Control Bionics is operating at the current time. Most of Control Bionics' value examination focuses on studying past and present price action to predict the probability of Control Bionics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Control Bionics' price. Additionally, you may evaluate how the addition of Control Bionics to your portfolios can decrease your overall portfolio volatility.